← Eichor
Condition: Pulmonary Alveolar Proteinosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pulmonary Alveolar Proteinosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Efficacy of PMT Therapy of hPAP
Phase 1/Phase 2 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05761899European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Phase N/A · 3 location(s) · Matthias Griese · NCT02852928A National Registry For Pulmonary Alveolar Proteinosis
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02461615Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
Phase 3 · 1 location(s) · Savara Inc. · NCT06431776
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.